Jörg Striessnig, Ph.D. - Publications

University of Innsbruck, Innsbruck, Tirol, Austria 
Calcium Channels

193 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Hofer NT, Pinggera A, Nikonishyna YV, Tuluc P, Fritz EM, Obermair GJ, Striessnig J. Stabilization of negative activation voltages of Cav1.3 L-Type Ca-channels by alternative splicing. Channels (Austin, Tex.). 15: 38-52. PMID 33380256 DOI: 10.1080/19336950.2020.1859260  0.56
2020 Ortner NJ, Kaserer T, Copeland JN, Striessnig J. Correction to: De novo CACNA1D Ca channelopathies: clinical phenotypes and molecular mechanism. Pflugers Archiv : European Journal of Physiology. 472: 1105. PMID 32666275 DOI: 10.1007/s00424-020-02436-8  0.52
2020 Ortner NJ, Kaserer T, Copeland JN, Striessnig J. De novo CACAN1D Ca channelopathies: clinical phenotypes and molecular mechanism. Pflugers Archiv : European Journal of Physiology. PMID 32583268 DOI: 10.1007/s00424-020-02418-w  0.52
2020 Hofer NT, Tuluc P, Ortner NJ, Nikonishyna YV, Fernándes-Quintero ML, Liedl KR, Flucher BE, Cox H, Striessnig J. Biophysical classification of a de novo mutation as a high-risk mutation for a severe neurodevelopmental disorder. Molecular Autism. 11: 4. PMID 31921405 DOI: 10.1186/s13229-019-0310-4  0.56
2019 Ortner NJ, Pinggera A, Hofer NT, Siller A, Brandt N, Raffeiner A, Vilusic K, Lang I, Blum K, Obermair GJ, Stefan E, Engel J, Striessnig J. RBP2 stabilizes slow Cav1.3 Ca channel inactivation properties of cochlear inner hair cells. Pflugers Archiv : European Journal of Physiology. PMID 31848688 DOI: 10.1007/s00424-019-02338-4  0.56
2018 Pinggera A, Negro G, Tuluc P, Brown MJ, Lieb A, Striessnig J. Gating defects of disease-causing de novo mutations in Ca1.3 Ca channels. Channels (Austin, Tex.). 12: 388-402. PMID 30465465 DOI: 10.1080/19336950.2018.1546518  0.56
2017 Monteleone S, Lieb A, Pinggera A, Negro G, Fuchs JE, Hofer F, Striessnig J, Tuluc P, Liedl KR. Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. Biophysical Journal. 113: 1485-1495. PMID 28978442 DOI: 10.1016/j.bpj.2017.08.010  0.56
2017 Ortner NJ, Bock G, Dougalis A, Kharitonova M, Duda J, Hess S, Tuluc P, Pomberger T, Stefanova N, Pitterl F, Ciossek T, Oberacher H, Draheim HJ, Kloppenburg P, Liss B, ... Striessnig J, et al. Lower affinity of isradipine for L-type Ca(2+) channels during substantia nigra dopamine neuron-like activity: implications for neuroprotection in Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28592699 DOI: 10.1523/JNEUROSCI.2946-16.2017  0.52
2017 Tan GC, Negro G, Pinggera A, Tizen Laim NMS, Mohamed Rose I, Ceral J, Ryska A, Chin LK, Kamaruddin NA, Mohd Mokhtar N, A Jamal AR, Sukor N, Solar M, Striessnig J, Brown MJ, et al. Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel CACNA1D Mutation. Hypertension (Dallas, Tex. : 1979). PMID 28584016 DOI: 10.1161/HYPERTENSIONAHA.117.09057  0.56
2017 Pinggera A, Mackenroth L, Rump A, Schallner J, Beleggia F, Wollnik B, Striessnig J. New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy. Human Molecular Genetics. PMID 28472301 DOI: 10.1093/hmg/ddx175  0.56
2017 Martínez-Rivera A, Hao J, Tropea TF, Giordano TP, Kosovsky M, Rice RC, Lee A, Huganir RL, Striessnig J, Addy NA, Han S, Rajadhyaksha AM. Enhancing VTA Cav1.3 L-type Ca(2+) channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens. Molecular Psychiatry. PMID 28194001 DOI: 10.1038/mp.2017.9  0.56
2017 Mastrolia V, Flucher SM, Obermair GJ, Drach M, Hofer H, Renström E, Schwartz A, Striessnig J, Flucher BE, Tuluc P. Loss of α2δ-1 Calcium Channel Subunit Function Increases the Susceptibility for Diabetes. Diabetes. PMID 28115397 DOI: 10.2337/db16-0336  0.56
2016 Stanika R, Campiglio M, Pinggera A, Lee A, Striessnig J, Flucher BE, Obermair GJ. Splice variants of the CaV1.3 L-type calcium channel regulate dendritic spine morphology. Scientific Reports. 6: 34528. PMID 27708393 DOI: 10.1038/srep34528  0.56
2016 Pinggera A, Striessnig J. Cav 1.3 (CACNA1D) L-type Ca(2+) channel dysfunction in CNS disorders. The Journal of Physiology. PMID 26842699 DOI: 10.1113/JP270672  0.56
2016 Mesirca P, Bidaud I, Briec F, Evain S, Torrente AG, Le Quang K, Leoni AL, Baudot M, Marger L, Chung You Chong A, Nargeot J, Striessnig J, Wickman K, Charpentier F, Mangoni ME. G protein-gated IKACh channels as therapeutic targets for treatment of sick sinus syndrome and heart block. Proceedings of the National Academy of Sciences of the United States of America. PMID 26831068 DOI: 10.1073/pnas.1517181113  1
2016 Torrente AG, Mesirca P, Neco P, Rizzetto R, Dubel S, Barrere C, Sinegger-Brauns M, Striessnig J, Richard S, Nargeot J, Gomez AM, Mangoni ME. L-type Cav1.3 Channels Regulate Ryanodine Receptor-dependent Ca2+ Release during Sino-Atrial Node Pacemaker Activity. Cardiovascular Research. PMID 26786159 DOI: 10.1093/cvr/cvw006  1
2015 Marschallinger J, Sah A, Schmuckermair C, Unger M, Rotheneichner P, Kharitonova M, Waclawiczek A, Gerner P, Jaksch-Bogensperger H, Berger S, Striessnig J, Singewald N, Couillard-Despres S, Aigner L. The L-type calcium channel Cav1.3 is required for proper hippocampal neurogenesis and cognitive functions. Cell Calcium. PMID 26459417 DOI: 10.1016/j.ceca.2015.09.007  1
2015 Poetschke C, Dragicevic E, Duda J, Benkert J, Dougalis A, DeZio R, Snutch TP, Striessnig J, Liss B. Compensatory T-type Ca(2+) channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca(2+) channel KO mice. Scientific Reports. 5: 13688. PMID 26381090 DOI: 10.1038/srep13688  1
2015 Scharinger A, Eckrich S, Vandael DH, Schönig K, Koschak A, Hecker D, Kaur G, Lee A, Sah A, Bartsch D, Benedetti B, Lieb A, Schick B, Singewald N, Sinnegger-Brauns MJ, ... ... Striessnig J, et al. Cell-type-specific tuning of Cav1.3 Ca(2+)-channels by a C-terminal automodulatory domain. Frontiers in Cellular Neuroscience. 9: 309. PMID 26379493 DOI: 10.3389/fncel.2015.00309  0.56
2015 Zamponi GW, Striessnig J, Koschak A, Dolphin AC. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmacological Reviews. 67: 821-70. PMID 26362469 DOI: 10.1124/pr.114.009654  1
2015 Kaur G, Pinggera A, Ortner NJ, Lieb A, Sinnegger-Brauns MJ, Yarov-Yarovoy V, Obermair GJ, Flucher BE, Striessnig J. A Polybasic Plasma Membrane Binding Motif in the I-II Linker Stabilizes Voltage-gated CaV1.2 Calcium Channel Function. The Journal of Biological Chemistry. 290: 21086-100. PMID 26100638 DOI: 10.1074/jbc.M115.645671  1
2015 Ortner NJ, Striessnig J. L-type calcium channels as drug targets in CNS disorders. Channels (Austin, Tex.). 1-7. PMID 26039257 DOI: 10.1080/19336950.2015.1048936  0.52
2015 Striessnig J, Ortner NJ, Pinggera A. Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets? Current Molecular Pharmacology. 8: 110-22. PMID 25966690  1
2015 Pinggera A, Lieb A, Benedetti B, Lampert M, Monteleone S, Liedl KR, Tuluc P, Striessnig J. CACNA1D de novo mutations in autism spectrum disorders activate Cav1.3 L-type calcium channels. Biological Psychiatry. 77: 816-22. PMID 25620733 DOI: 10.1016/j.biopsych.2014.11.020  1
2015 Yang G, Shi Y, Yu J, Li Y, Yu L, Welling A, Hofmann F, Striessnig J, Juntti-Berggren L, Berggren PO, Yang SN. CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. Cellular and Molecular Life Sciences : Cmls. 72: 1197-207. PMID 25292336 DOI: 10.1007/s00018-014-1737-6  1
2015 Scharinger A, Eckrich S, Vandael DH, Schönig K, Koschak A, Hecker D, Kaur G, Lee A, Sah A, Bartsch D, Benedetti B, Lieb A, Schick B, Singewald N, Sinnegger-Brauns MJ, ... ... Striessnig J, et al. Cell-type-specific tuning of Cav1.3 Ca2+-channels by a C-terminal automodulatory domain Frontiers in Cellular Neuroscience. 9. DOI: 10.3389/fncel.2015.00309  1
2014 Gstir R, Schafferer S, Scheideler M, Misslinger M, Griehl M, Daschil N, Humpel C, Obermair GJ, Schmuckermair C, Striessnig J, Flucher BE, Hüttenhofer A. Generation of a neuro-specific microarray reveals novel differentially expressed noncoding RNAs in mouse models for neurodegenerative diseases. Rna (New York, N.Y.). 20: 1929-43. PMID 25344396 DOI: 10.1261/rna.047225.114  1
2014 Ortner NJ, Bock G, Vandael DH, Mauersberger R, Draheim HJ, Gust R, Carbone E, Tuluc P, Striessnig J. Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. Nature Communications. 5: 3897. PMID 24941892 DOI: 10.1038/ncomms4897  1
2014 Dragicevic E, Poetschke C, Duda J, Schlaudraff F, Lammel S, Schiemann J, Fauler M, Hetzel A, Watanabe M, Lujan R, Malenka RC, Striessnig J, Liss B. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. Brain : a Journal of Neurology. 137: 2287-302. PMID 24934288 DOI: 10.1093/brain/awu131  1
2014 Liu Y, Harding M, Pittman A, Dore J, Striessnig J, Rajadhyaksha A, Chen X. Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area. Journal of Neurophysiology. 112: 1119-30. PMID 24848473 DOI: 10.1152/jn.00757.2013  1
2014 Lieb A, Ortner N, Striessnig J. C-terminal modulatory domain controls coupling of voltage-sensing to pore opening in Cav1.3 L-type Ca(2+) channels. Biophysical Journal. 106: 1467-75. PMID 24703308 DOI: 10.1016/j.bpj.2014.02.017  1
2014 Striessnig J, Pinggera A, Kaur G, Bock G, Tuluc P. L-type Ca(2+) channels in heart and brain. Wiley Interdisciplinary Reviews. Membrane Transport and Signaling. 3: 15-38. PMID 24683526 DOI: 10.1002/wmts.102  1
2014 Koschak A, Pinggera A, Schicker K, Striessnig J. Role of L-type Ca2+ channels in sensory cells Pathologies of Calcium Channels. 47-75. DOI: 10.1007/978-3-642-40282-1_3  1
2013 Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A, Maniero C, Garg S, Bochukova EG, Zhao W, Shaikh LH, Brighton CA, Teo AE, Davenport AP, Dekkers T, ... ... Striessnig J, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nature Genetics. 45: 1055-60. PMID 23913004 DOI: 10.1038/ng.2716  1
2013 Striessnig J. Lonely but diverse: Cav1.3 L-type Ca(2+) channels in cochlear inner hair cells. Channels (Austin, Tex.). 7: 133-4. PMID 23567254 DOI: 10.4161/chan.24457  1
2012 Vandael DH, Zuccotti A, Striessnig J, Carbone E. Ca(V)1.3-driven SK channel activation regulates pacemaking and spike frequency adaptation in mouse chromaffin cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 16345-59. PMID 23152617 DOI: 10.1523/JNEUROSCI.3715-12.2012  1
2012 Christel CJ, Cardona N, Mesirca P, Herrmann S, Hofmann F, Striessnig J, Ludwig A, Mangoni ME, Lee A. Distinct localization and modulation of Cav1.2 and Cav1.3 L-type Ca2+ channels in mouse sinoatrial node. The Journal of Physiology. 590: 6327-42. PMID 23045342 DOI: 10.1113/jphysiol.2012.239954  1
2012 Lieb A, Scharinger A, Sartori S, Sinnegger-Brauns MJ, Striessnig J. Structural determinants of CaV1.3 L-type calcium channel gating. Channels (Austin, Tex.). 6: 197-205. PMID 22760075 DOI: 10.4161/chan.21002  1
2012 Jurkovičová-Tarabová B, Griesemer D, Pirone A, Sinnegger-Brauns MJ, Striessnig J, Friauf E. Repertoire of high voltage-activated Ca2+ channels in the lateral superior olive: functional analysis in wild-type, Ca(v)1.3(-/-), and Ca(v)1.2DHP(-/-) mice. Journal of Neurophysiology. 108: 365-79. PMID 22539826 DOI: 10.1152/jn.00948.2011  1
2012 Schierberl K, Giordano T, Satpute S, Hao J, Kaur G, Hofmann F, Moosmang S, Striessnig J, Rajadhyaksha A. Cav 1.3 L-type Ca ( 2+) channels mediate long-term adaptation in dopamine D2L-mediated GluA1 trafficking in the dorsal striatum following cocaine exposure. Channels (Austin, Tex.). 6: 11-7. PMID 22419037 DOI: 10.4161/chan.19324  1
2012 Kaehler ST, Baumgartner H, Jeske M, Anliker M, Schennach H, Marschang P, Ratt A, Colvin AC, Falk J, Gasser A, Kirchebner J, Scherer C, Purtscher AE, Griesmacher A, Striessnig J. Prevalence of hypovitaminosis D and folate deficiency in healthy young female Austrian students in a health care profession. European Journal of Nutrition. 51: 1021-31. PMID 22116202 DOI: 10.1007/s00394-011-0281-5  1
2012 Schierberl K, Giordano T, Satpute S, Hao J, Kaur G, Hofmann F, Moosmang S, Striessnig J, Rajadhyaksha A. Cav1.3 L-type Ca2+ channels mediate long-term adaptation in dopamine D2L-mediated GluA1 trafficking in the dorsal striatum following cocaine exposure Channels. 6. DOI: 10.4161/chan.6.1.19324  1
2011 Bock G, Gebhart M, Scharinger A, Jangsangthong W, Busquet P, Poggiani C, Sartori S, Mangoni ME, Sinnegger-Brauns MJ, Herzig S, Striessnig J, Koschak A. Functional properties of a newly identified C-terminal splice variant of Cav1.3 L-type Ca2+ channels. The Journal of Biological Chemistry. 286: 42736-48. PMID 21998310 DOI: 10.1074/jbc.M111.269951  1
2011 Schierberl K, Hao J, Tropea TF, Ra S, Giordano TP, Xu Q, Garraway SM, Hofmann F, Moosmang S, Striessnig J, Inturrisi CE, Rajadhyaksha AM. Cav1.2 L-type Ca²⁺ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Ca(v)1.3 channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 13562-75. PMID 21940447 DOI: 10.1523/JNEUROSCI.2315-11.2011  1
2011 Rose RA, Sellan M, Simpson JA, Izaddoustdar F, Cifelli C, Panama BK, Davis M, Zhao D, Markhani M, Murphy GG, Striessnig J, Liu PP, Heximer SP, Backx PH. Iron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation. Circulation. Arrhythmia and Electrophysiology. 4: 733-42. PMID 21747058 DOI: 10.1161/CIRCEP.110.960401  1
2011 Hirtz JJ, Boesen M, Braun N, Deitmer JW, Kramer F, Lohr C, Müller B, Nothwang HG, Striessnig J, Löhrke S, Friauf E. Cav1.3 calcium channels are required for normal development of the auditory brainstem. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 8280-94. PMID 21632949 DOI: 10.1523/JNEUROSCI.5098-10.2011  1
2011 Marger L, Mesirca P, Alig J, Torrente A, Dubel S, Engeland B, Kanani S, Fontanaud P, Striessnig J, Shin HS, Isbrandt D, Ehmke H, Nargeot J, Mangoni ME. Functional roles of Ca(v)1.3, Ca(v)3.1 and HCN channels in automaticity of mouse atrioventricular cells: insights into the atrioventricular pacemaker mechanism. Channels (Austin, Tex.). 5: 251-61. PMID 21406960 DOI: 10.4161/chan.5.3.15266  1
2011 Marger L, Mesirca P, Alig J, Torrente A, Dubel S, Engeland B, Kanani S, Fontanaud P, Striessnig J, Shin HS, Isbrandt D, Ehmke H, Nargeot J, Mangoni ME. Pacemaker activity and ionic currents in mouse atrioventricular node cells. Channels (Austin, Tex.). 5: 241-50. PMID 21406959  1
2011 Baig SM, Koschak A, Lieb A, Gebhart M, Dafinger C, Nürnberg G, Ali A, Ahmad I, Sinnegger-Brauns MJ, Brandt N, Engel J, Mangoni ME, Farooq M, Khan HU, Nürnberg P, ... Striessnig J, et al. Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nature Neuroscience. 14: 77-84. PMID 21131953 DOI: 10.1038/nn.2694  1
2011 Marger L, Mesirca P, Alig J, Torrente A, Dubel S, Engeland B, Kanani S, Fontanaud P, Striessnig J, Shin HS, Isbrandt D, Ehmke H, Nargeot J, Mangoni ME. Functional roles of Cav1.3, Cav3.1 and HCN channels in automaticity of mouse atrioventricular cells: Insights into the atrioventricular pacemaker mechanism Channels. 5.  1
2011 Mahapatra S, Marcantoni A, Vandael DHF, Striessnig J, Carbone E. Are Ca v1.3 pacemaker channels in chromaffin cells? Possible bias from resting cell conditions and DHP blocker usage Channels. 5.  1
2010 Giordano TP, Tropea TF, Satpute SS, Sinnegger-Brauns MJ, Striessnig J, Kosofsky BE, Rajadhyaksha AM. Molecular switch from L-type Ca v 1.3 to Ca v 1.2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 17051-62. PMID 21159975 DOI: 10.1523/JNEUROSCI.2255-10.2010  1
2010 Müller CS, Haupt A, Bildl W, Schindler J, Knaus HG, Meissner M, Rammner B, Striessnig J, Flockerzi V, Fakler B, Schulte U. Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 107: 14950-7. PMID 20668236 DOI: 10.1073/pnas.1005940107  1
2010 Gebhart M, Juhasz-Vedres G, Zuccotti A, Brandt N, Engel J, Trockenbacher A, Kaur G, Obermair GJ, Knipper M, Koschak A, Striessnig J. Modulation of Cav1.3 Ca2+ channel gating by Rab3 interacting molecule. Molecular and Cellular Neurosciences. 44: 246-59. PMID 20363327 DOI: 10.1016/j.mcn.2010.03.011  1
2010 Striessnig J, Bolz HJ, Koschak A. Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels. PflüGers Archiv : European Journal of Physiology. 460: 361-74. PMID 20213496 DOI: 10.1007/s00424-010-0800-x  1
2010 Marcantoni A, Vandael DH, Mahapatra S, Carabelli V, Sinnegger-Brauns MJ, Striessnig J, Carbone E. Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 491-504. PMID 20071512 DOI: 10.1523/JNEUROSCI.4961-09.2010  0.52
2010 Busquet P, Nguyen NK, Schmid E, Tanimoto N, Seeliger MW, Ben-Yosef T, Mizuno F, Akopian A, Striessnig J, Singewald N. CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 499-513. PMID 19664321 DOI: 10.1017/S1461145709990368  1
2009 Striessnig J. An oily competition: role of beta subunit palmitoylation for Ca2+ channel modulation by fatty acids. The Journal of General Physiology. 134: 363-7. PMID 19858356 DOI: 10.1085/jgp.200910330  1
2009 Subramanyam P, Obermair GJ, Baumgartner S, Gebhart M, Striessnig J, Kaufmann WA, Geley S, Flucher BE. Activity and calcium regulate nuclear targeting of the calcium channel beta4b subunit in nerve and muscle cells. Channels (Austin, Tex.). 3: 343-55. PMID 19755859  1
2009 Horak S, Koschak A, Stuppner H, Striessnig J. Use-dependent block of voltage-gated Cav2.1 Ca2+ channels by petasins and eudesmol isomers. The Journal of Pharmacology and Experimental Therapeutics. 330: 220-6. PMID 19369579 DOI: 10.1124/jpet.109.151183  1
2009 Bova S, Saponara S, Rampa A, Gobbi S, Cima L, Fusi F, Sgaragli G, Cavalli M, de los Rios C, Striessnig J, Bisi A. Anthracene based compounds as new L-type Ca2+ channel blockers: design, synthesis, and full biological profile. Journal of Medicinal Chemistry. 52: 1259-62. PMID 19203272 DOI: 10.1021/jm801589x  1
2009 Sinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, Hoda JC, Sartori SB, Striessnig J. Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Molecular Pharmacology. 75: 407-14. PMID 19029287 DOI: 10.1124/mol.108.049981  1
2009 Subramanyam P, Obermair GJ, Baumgartner S, Gebhart M, Striessnig J, Kaufmann WA, Geley S, Flucher BE. Activity and calcium regulate nuclear targeting of the calcium channel β4b subunit in nerve and muscle cells Channels. 3.  1
2008 Watschinger K, Horak SB, Schulze K, Obermair GJ, Wild C, Koschak A, Sinnegger-Brauns MJ, Tampé R, Striessnig J. Functional properties and modulation of extracellular epitope-tagged Ca(V)2.1 voltage-gated calcium channels. Channels (Austin, Tex.). 2: 461-73. PMID 18797193 DOI: 10.4161/chan.2.6.6793  1
2008 Striessnig J, Koschak A. Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene knockout models. Channels (Austin, Tex.). 2: 233-51. PMID 18719397 DOI: 10.4161/chan.2.4.5847  1
2008 Singh A, Gebhart M, Fritsch R, Sinnegger-Brauns MJ, Poggiani C, Hoda JC, Engel J, Romanin C, Striessnig J, Koschak A. Modulation of voltage- and Ca2+-dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain. The Journal of Biological Chemistry. 283: 20733-44. PMID 18482979 DOI: 10.1074/jbc.M802254200  1
2008 Busquet P, Hetzenauer A, Sinnegger-Brauns MJ, Striessnig J, Singewald N. Role of L-type Ca2+ channel isoforms in the extinction of conditioned fear. Learning & Memory (Cold Spring Harbor, N.Y.). 15: 378-86. PMID 18441296 DOI: 10.1101/lm.886208  1
2008 Mezghrani A, Monteil A, Watschinger K, Sinnegger-Brauns MJ, Barrère C, Bourinet E, Nargeot J, Striessnig J, Lory P. A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 4501-11. PMID 18434528 DOI: 10.1523/JNEUROSCI.2844-07.2008  1
2008 Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J, Wratten J, Davies A, Dolphin AC. Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin. Proceedings of the National Academy of Sciences of the United States of America. 105: 3628-33. PMID 18299583 DOI: 10.1073/pnas.0708930105  1
2007 Striessnig J. C-terminal tailoring of L-type calcium channel function. The Journal of Physiology. 585: 643-4. PMID 18084049 DOI: 10.1113/jphysiol.2007.147140  1
2007 Navedo MF, Amberg GC, Westenbroek RE, Sinnegger-Brauns MJ, Catterall WA, Striessnig J, Santana LF. Ca(v)1.3 channels produce persistent calcium sparklets, but Ca(v)1.2 channels are responsible for sparklets in mouse arterial smooth muscle. American Journal of Physiology. Heart and Circulatory Physiology. 293: H1359-70. PMID 17526649 DOI: 10.1152/ajpheart.00450.2007  1
2007 Koschak A, Obermair GJ, Pivotto F, Sinnegger-Brauns MJ, Striessnig J, Pietrobon D. Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3855-63. PMID 17409250 DOI: 10.1523/JNEUROSCI.4028-06.2007  1
2007 Wu J, Marmorstein AD, Striessnig J, Peachey NS. Voltage-dependent calcium channel CaV1.3 subunits regulate the light peak of the electroretinogram. Journal of Neurophysiology. 97: 3731-5. PMID 17376851 DOI: 10.1152/jn.00146.2007  1
2007 Erazo-Fischer E, Striessnig J, Taschenberger H. The role of physiological afferent nerve activity during in vivo maturation of the calyx of Held synapse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 1725-37. PMID 17301180 DOI: 10.1523/JNEUROSCI.4116-06.2007  1
2007 Zhang J, Berra-Romani R, Sinnegger-Brauns MJ, Striessnig J, Blaustein MP, Matteson DR. Role of Cav1.2 L-type Ca2+ channels in vascular tone: effects of nifedipine and Mg2+. American Journal of Physiology. Heart and Circulatory Physiology. 292: H415-25. PMID 16980345 DOI: 10.1152/ajpheart.01214.2005  1
2006 Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen NK, Busquet P, Pelster G, Singewald N. Role of voltage-gated L-type Ca2+ channel isoforms for brain function. Biochemical Society Transactions. 34: 903-9. PMID 17052224 DOI: 10.1042/BST0340903  1
2006 Giordano TP, Satpute SS, Striessnig J, Kosofsky BE, Rajadhyaksha AM. Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels. Journal of Neurochemistry. 99: 1197-206. PMID 17026527 DOI: 10.1111/j.1471-4159.2006.04186.x  1
2006 Singh A, Hamedinger D, Hoda JC, Gebhart M, Koschak A, Romanin C, Striessnig J. C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. Nature Neuroscience. 9: 1108-16. PMID 16921373 DOI: 10.1038/nn1751  1
2006 Hetzenauer A, Sinnegger-Brauns MJ, Striessnig J, Singewald N. Brain activation pattern induced by stimulation of L-type Ca2+-channels: contribution of Ca(V)1.3 and Ca(V)1.2 isoforms. Neuroscience. 139: 1005-15. PMID 16542784 DOI: 10.1016/j.neuroscience.2006.01.059  1
2006 Hoda JC, Zaghetto F, Singh A, Koschak A, Striessnig J. Effects of congenital stationary night blindness type 2 mutations R508Q and L1364H on Cav1.4 L-type Ca2+ channel function and expression. Journal of Neurochemistry. 96: 1648-58. PMID 16476079 DOI: 10.1111/j.1471-4159.2006.03678.x  1
2006 Mangoni ME, Couette B, Marger L, Bourinet E, Striessnig J, Nargeot J. Voltage-dependent calcium channels and cardiac pacemaker activity: from ionic currents to genes. Progress in Biophysics and Molecular Biology. 90: 38-63. PMID 15979127 DOI: 10.1016/j.pbiomolbio.2005.05.003  1
2005 Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J. International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacological Reviews. 57: 411-25. PMID 16382099 DOI: 10.1124/pr.57.4.5  1
2005 Hemara-Wahanui A, Berjukow S, Hope CI, Dearden PK, Wu SB, Wilson-Wheeler J, Sharp DM, Lundon-Treweek P, Clover GM, Hoda JC, Striessnig J, Marksteiner R, Hering S, Maw MA. A CACNA1F mutation identified in an X-linked retinal disorder shifts the voltage dependence of Cav1.4 channel activation. Proceedings of the National Academy of Sciences of the United States of America. 102: 7553-8. PMID 15897456 DOI: 10.1073/pnas.0501907102  1
2005 Hoda JC, Zaghetto F, Koschak A, Striessnig J. Congenital stationary night blindness type 2 mutations S229P, G369D, L1068P, and W1440X alter channel gating or functional expression of Ca(v)1.4 L-type Ca2+ channels. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 252-9. PMID 15634789 DOI: 10.1523/JNEUROSCI.3054-04.2005  1
2005 Striessnig J. Pathophysiology of migraine headache: Insight from pharmacology and genetics Drug Discovery Today: Disease Mechanisms. 2: 453-462. DOI: 10.1016/j.ddmec.2005.11.002  1
2004 Huber IG, Wappl-Kornherr E, Sinnegger-Brauns MJ, Hoda JC, Walter-Bastl D, Striessnig J. Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels. The Journal of Biological Chemistry. 279: 55211-7. PMID 15504730 DOI: 10.1074/jbc.M409008200  1
2004 Müllner C, Broos LA, van den Maagdenberg AM, Striessnig J. Familial hemiplegic migraine type 1 mutations K1336E, W1684R, and V1696I alter Cav2.1 Ca2+ channel gating: evidence for beta-subunit isoform-specific effects. The Journal of Biological Chemistry. 279: 51844-50. PMID 15448138 DOI: 10.1074/jbc.M408756200  1
2004 Striessnig J, Hoda JC, Koschak A, Zaghetto F, Müllner C, Sinnegger-Brauns MJ, Wild C, Watschinger K, Trockenbacher A, Pelster G. L-type Ca2+ channels in Ca2+ channelopathies. Biochemical and Biophysical Research Communications. 322: 1341-6. PMID 15336981 DOI: 10.1016/j.bbrc.2004.08.039  1
2004 Kugler G, Grabner M, Platzer J, Striessnig J, Flucher BE. The monoclonal antibody mAB 1A binds to the excitation--contraction coupling domain in the II-III loop of the skeletal muscle calcium channel alpha(1S) subunit. Archives of Biochemistry and Biophysics. 427: 91-100. PMID 15178491 DOI: 10.1016/j.abb.2004.04.007  1
2004 Matthes J, Yildirim L, Wietzorrek G, Reimer D, Striessnig J, Herzig S. Disturbed atrio-ventricular conduction and normal contractile function in isolated hearts from Cav1.3-knockout mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 369: 554-62. PMID 15146309 DOI: 10.1007/s00210-004-0940-7  1
2004 Sinnegger-Brauns MJ, Hetzenauer A, Huber IG, Renström E, Wietzorrek G, Berjukov S, Cavalli M, Walter D, Koschak A, Waldschütz R, Hering S, Bova S, Rorsman P, Pongs O, Singewald N, et al. Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca 2+ channels. The Journal of Clinical Investigation. 113: 1430-9. PMID 15146240 DOI: 10.1172/JCI20208  1
2003 Catterall WA, Striessnig J, Snutch TP, Perez-Reyes E. International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels. Pharmacological Reviews. 55: 579-81. PMID 14657414 DOI: 10.1124/pr.55.4.8  1
2003 Brandt A, Striessnig J, Moser T. CaV1.3 channels are essential for development and presynaptic activity of cochlear inner hair cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10832-40. PMID 14645476  1
2003 Michna M, Knirsch M, Hoda JC, Muenkner S, Langer P, Platzer J, Striessnig J, Engel J. Cav1.3 (alpha1D) Ca2+ currents in neonatal outer hair cells of mice. The Journal of Physiology. 553: 747-58. PMID 14514878 DOI: 10.1113/jphysiol.2003.053256  1
2003 Wolf M, Eberhart A, Glossmann H, Striessnig J, Grigorieff N. Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. Journal of Molecular Biology. 332: 171-82. PMID 12946355 DOI: 10.1016/S0022-2836(03)00899-4  1
2003 Clark NC, Nagano N, Kuenzi FM, Jarolimek W, Huber I, Walter D, Wietzorrek G, Boyce S, Kullmann DM, Striessnig J, Seabrook GR. Neurological phenotype and synaptic function in mice lacking the CaV1.3 alpha subunit of neuronal L-type voltage-dependent Ca2+ channels. Neuroscience. 120: 435-42. PMID 12890513 DOI: 10.1016/S0306-4522(03)00329-4  1
2003 Koschak A, Reimer D, Walter D, Hoda JC, Heinzle T, Grabner M, Striessnig J. Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6041-9. PMID 12853422  1
2003 Pietrobon D, Striessnig J. Neurobiology of migraine. Nature Reviews. Neuroscience. 4: 386-98. PMID 12728266 DOI: 10.1038/nrn1102  1
2003 Mangoni ME, Couette B, Bourinet E, Platzer J, Reimer D, Striessnig J, Nargeot J. Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity. Proceedings of the National Academy of Sciences of the United States of America. 100: 5543-8. PMID 12700358 DOI: 10.1073/pnas.0935295100  1
2003 Glueckert R, Wietzorrek G, Kammen-Jolly K, Scholtz A, Stephan K, Striessnig J, Schrott-Fischer A. Role of class D L-type Ca2+ channels for cochlear morphology. Hearing Research. 178: 95-105. PMID 12684182 DOI: 10.1016/S0378-5955(03)00054-6  1
2002 Tottene A, Fellin T, Pagnutti S, Luvisetto S, Striessnig J, Fletcher C, Pietrobon D. Familial hemiplegic migraine mutations increase Ca(2+) influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proceedings of the National Academy of Sciences of the United States of America. 99: 13284-9. PMID 12235360 DOI: 10.1073/pnas.192242399  1
2002 Hitzl M, Striessnig J, Neuhuber B, Flucher BE. A mutation in the beta interaction domain of the Ca(2+) channel alpha(1C) subunit reduces the affinity of the (+)-[(3)H]isradipine binding site. Febs Letters. 524: 188-92. PMID 12135765 DOI: 10.1016/S0014-5793(02)03054-5  1
2002 Day M, Olson PA, Platzer J, Striessnig J, Surmeier DJ. Stimulation of 5-HT(2) receptors in prefrontal pyramidal neurons inhibits Ca(v)1.2 L type Ca(2+) currents via a PLCbeta/IP3/calcineurin signaling cascade. Journal of Neurophysiology. 87: 2490-504. PMID 11976386 DOI: 10.1152/jn.00843.2001  1
2002 Engel J, Michna M, Platzer J, Striessnig J. Calcium channels in mouse hair cells: function, properties and pharmacology. Advances in Oto-Rhino-Laryngology. 59: 35-41. PMID 11885659  1
2002 Wappl E, Koschak A, Poteser M, Sinnegger MJ, Walter D, Eberhart A, Groschner K, Glossmann H, Kraus RL, Grabner M, Striessnig J. Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. The Journal of Biological Chemistry. 277: 6960-6. PMID 11742003 DOI: 10.1074/jbc.M110948200  1
2001 Barg S, Ma X, Eliasson L, Galvanovskis J, Göpel SO, Obermüller S, Platzer J, Renström E, Trus M, Atlas D, Striessnig J, Rorsman P. Fast exocytosis with few Ca(2+) channels in insulin-secreting mouse pancreatic B cells. Biophysical Journal. 81: 3308-23. PMID 11720994 DOI: 10.1016/S0006-3495(01)75964-4  1
2001 Striessnig J. Targeting voltage-gated Ca2+ channels. Lancet. 357: 1294. PMID 11421217 DOI: 10.1016/S0140-6736(00)04440-8  1
2001 Koschak A, Reimer D, Huber I, Grabner M, Glossmann H, Engel J, Striessnig J. alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. The Journal of Biological Chemistry. 276: 22100-6. PMID 11285265 DOI: 10.1074/jbc.M101469200  1
2001 Wappl E, Mitterdorfer J, Glossmann H, Striessnig J. Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits. The Journal of Biological Chemistry. 276: 12730-5. PMID 11278630 DOI: 10.1074/jbc.M010164200  1
2001 Liu X, Rusch NJ, Striessnig J, Sarna SK. Down-regulation of L-type calcium channels in inflamed circular smooth muscle cells of the canine colon. Gastroenterology. 120: 480-9. PMID 11159888 DOI: 10.1053/gast.2001.21167  1
2000 Seisenberger C, Specht V, Welling A, Platzer J, Pfeifer A, Kühbandner S, Striessnig J, Klugbauer N, Feil R, Hofmann F. Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. The Journal of Biological Chemistry. 275: 39193-9. PMID 10973973 DOI: 10.1074/jbc.M006467200  1
2000 Platzer J, Engel J, Schrott-Fischer A, Stephan K, Bova S, Chen H, Zheng H, Striessnig J. Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell. 102: 89-97. PMID 10929716  1
2000 Matthes J, Huber I, Haaf O, Antepohl W, Striessnig J, Herzig S. Pharmacodynamic interaction between mibefradil and other calcium channel blockers. Naunyn-Schmiedeberg's Archives of Pharmacology. 361: 578-83. PMID 10882031 DOI: 10.1007/s002100000239  1
2000 Eller P, Berjukov S, Wanner S, Huber I, Hering S, Knaus HG, Toth G, Kimball SD, Striessnig J. High affinity interaction of mibefradil with voltage-gated calcium and sodium channels. British Journal of Pharmacology. 130: 669-77. PMID 10821797 DOI: 10.1038/sj.bjp.0703352  1
2000 Huber I, Wappl E, Herzog A, Mitterdorfer J, Glossmann H, Langer T, Striessnig J. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. The Biochemical Journal. 347: 829-36. PMID 10769189 DOI: 10.1042/0264-6021:3470829  1
2000 Kraus RL, Sinnegger MJ, Koschak A, Glossmann H, Stenirri S, Carrera P, Striessnig J. Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. The Journal of Biological Chemistry. 275: 9239-43. PMID 10734061 DOI: 10.1074/jbc.275.13.9239  1
2000 Reimer D, Huber IG, Garcia ML, Haase H, Striessnig J. beta subunit heterogeneity of L-type Ca(2+) channels in smooth muscle tissues. Febs Letters. 467: 65-9. PMID 10664458 DOI: 10.1016/S0014-5793(00)01124-8  1
1999 Striessnig J. Pharmacology, structure and function of cardiac L-type Ca(2+) channels. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 9: 242-69. PMID 10575201  1
1999 Gerster U, Neuhuber B, Groschner K, Striessnig J, Flucher BE. Current modulation and membrane targeting of the calcium channel alpha1C subunit are independent functions of the beta subunit. The Journal of Physiology. 517: 353-68. PMID 10332087 DOI: 10.1111/j.1469-7793.1999.0353t.x  1
1999 Leitner B, Lovisetti-Scamihorn P, Heilmann J, Striessnig J, Blakely RD, Eiden LE, Winkler H. Subcellular localization of chromogranins, calcium channels, amine carriers, and proteins of the exocytotic machinery in bovine splenic nerve. Journal of Neurochemistry. 72: 1110-6. PMID 10037482 DOI: 10.1046/j.1471-4159.1999.0721110.x  1
1998 Kraus RL, Hering S, Grabner M, Ostler D, Striessnig J. Molecular mechanism of diltiazem interaction with L-type Ca2+ channels. The Journal of Biological Chemistry. 273: 27205-12. PMID 9765241 DOI: 10.1074/jbc.273.42.27205  1
1998 Mitterdorfer J, Grabner M, Kraus RL, Hering S, Prinz H, Glossmann H, Striessnig J. Molecular basis of drug interaction with L-type Ca2+ channels. Journal of Bioenergetics and Biomembranes. 30: 319-34. PMID 9758329 DOI: 10.1023/A:1021933504909  1
1998 Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H. Structural basis of drug binding to L Ca2+ channels. Trends in Pharmacological Sciences. 19: 108-15. PMID 9584627 DOI: 10.1016/S0165-6147(98)01171-7  1
1998 Kraus RL, Sinnegger MJ, Glossmann H, Hering S, Striessnig J. Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. The Journal of Biological Chemistry. 273: 5586-90. PMID 9488686 DOI: 10.1074/jbc.273.10.5586  1
1997 Hering S, Aczél S, Kraus RL, Berjukow S, Striessnig J, Timin EN. Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation. Proceedings of the National Academy of Sciences of the United States of America. 94: 13323-8. PMID 9371844 DOI: 10.1073/pnas.94.24.13323  1
1997 Sinnegger MJ, Wang Z, Grabner M, Hering S, Striessnig J, Glossmann H, Mitterdorfer J. Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. The Journal of Biological Chemistry. 272: 27686-93. PMID 9346909 DOI: 10.1074/jbc.272.44.27686  1
1997 Pichler M, Cassidy TN, Reimer D, Haase H, Kraus R, Ostler D, Striessnig J. Beta subunit heterogeneity in neuronal L-type Ca2+ channels. The Journal of Biological Chemistry. 272: 13877-82. PMID 9153247 DOI: 10.1074/jbc.272.21.13877  1
1997 Safayhi H, Haase H, Kramer U, Bihlmayer A, Roenfeldt M, Ammon HP, Froschmayr M, Cassidy TN, Morano I, Ahlijanian MK, Striessnig J. L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINm5F cells. Molecular Endocrinology (Baltimore, Md.). 11: 619-29. PMID 9139805 DOI: 10.1210/mend.11.5.9922  1
1997 Moebius FF, Striessnig J, Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends in Pharmacological Sciences. 18: 67-70. PMID 9133773 DOI: 10.1016/S0165-6147(96)01037-1  1
1997 Brauns T, Prinz H, Kimball SD, Haugland RP, Striessnig J, Glossmann H. L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other. Biochemistry. 36: 3625-31. PMID 9132014 DOI: 10.1021/bi9613584  1
1997 Hinterdorfer P, Gruber HJ, Striessnig J, Glossmann H, Schindler H. Analysis of membrane protein self-association in lipid systems by fluorescence particle counting: application to the dihydropyridine receptor. Biochemistry. 36: 4497-504. PMID 9109657 DOI: 10.1021/bi962009c  1
1996 Mitterdorfer J, Wang Z, Sinnegger MJ, Hering S, Striessnig J, Grabner M, Glossmann H. Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity. The Journal of Biological Chemistry. 271: 30330-5. PMID 8939992 DOI: 10.1074/jbc.271.48.30330  1
1996 Berjukov S, Aczel S, Beyer B, Kimball SD, Dichtl M, Hering S, Striessnig J. Extra- and intracellular action of quaternary devapamil on muscle L-type Ca(2+)-channels. British Journal of Pharmacology. 119: 1197-202. PMID 8937723 DOI: 10.1111/j.1476-5381.1996.tb16022.x  1
1996 Pichler M, Wang Z, Grabner-Weiss C, Reimer D, Hering S, Grabner M, Glossmann H, Striessnig J. Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry. 35: 14659-64. PMID 8931565 DOI: 10.1021/bi961657t  1
1996 Hering S, Aczél S, Grabner M, Döring F, Berjukow S, Mitterdorfer J, Sinnegger MJ, Striessnig J, Degtiar VE, Wang Z, Glossmann H. Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels. The Journal of Biological Chemistry. 271: 24471-5. PMID 8798706 DOI: 10.1074/jbc.271.40.24471  1
1996 Mitterdorfer J, Froschmayr M, Grabner M, Moebius FF, Glossmann H, Striessnig J. Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry. 35: 9400-6. PMID 8755718 DOI: 10.1021/bi960683o  1
1996 Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proceedings of the National Academy of Sciences of the United States of America. 93: 8072-7. PMID 8755605 DOI: 10.1073/pnas.93.15.8072  1
1996 Kraus R, Reichl B, Kimball SD, Grabner M, Murphy BJ, Catterall WA, Striessnig J. Identification of benz(othi)azepine-binding regions within L-type calcium channel alpha1 subunits. The Journal of Biological Chemistry. 271: 20113-8. PMID 8702733 DOI: 10.1074/jbc.271.33.20113  1
1996 Döring F, Degtiar VE, Grabner M, Striessnig J, Hering S, Glossman H. Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha1A. The Journal of Biological Chemistry. 271: 11745-9. PMID 8662622 DOI: 10.1074/jbc.271.20.11745  1
1996 Boer R, Dichtl M, Borchers C, Ulrich WR, Marecek JF, Prestwich GD, Glossmann H, Striessnig J. Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor. Biochemistry. 35: 1387-96. PMID 8634268 DOI: 10.1021/bi951912u  1
1996 Thévenod F, Hildebrandt JP, Striessnig J, de Jonge HR, Schulz I. Chloride and potassium conductances of mouse pancreatic zymogen granules are inversely regulated by a approximately 80-kDa mdr1a gene product. The Journal of Biological Chemistry. 271: 3300-5. PMID 8621734 DOI: 10.1074/jbc.271.6.3300  1
1996 Grabner M, Wang Z, Hering S, Striessnig J, Glossmann H. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron. 16: 207-18. PMID 8562085 DOI: 10.1016/S0896-6273(00)80037-9  1
1996 Thévenod F, Striessnig J, Haase W, Anderie I, Hildebrandt JP, De Jonge HR, Schulz I. Functional relationship between a 65-kD mdr1 P-glycoprotein and ATP-activated chloride conductance in pancreatic zymogen granule membranes Cellular Physiology and Biochemistry. 6: 91-104.  1
1995 Dietl P, Haller T, Wirleitner B, Völkl H, Friedrich F, Striessnig J. Activation of L-type Ca2+ channels after purinoceptor stimulation by ATP in an alveolar epithelial cell (L2). The American Journal of Physiology. 269: L873-83. PMID 8572250  1
1995 Brauns T, Cai ZW, Kimball SD, Kang KC, Haugland RP, Berger W, Berjukov S, Hering S, Glossmann H, Striessnig J. Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue. Biochemistry. 34: 3461-9. PMID 7880840  1
1995 Hanner M, Moebius FF, Weber F, Grabner M, Striessnig J, Glossmann H. Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. The Journal of Biological Chemistry. 270: 7551-7. PMID 7706302 DOI: 10.1074/JBC.270.13.7551  1
1995 Mitterdorfer J, Sinnegger MJ, Grabner M, Striessnig J, Glossmann H. Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit. Biochemistry. 34: 9350-5. PMID 7626604  1
1994 Grabner M, Bachmann A, Rosenthal F, Striessnig J, Schultz C, Tautz D, Glossmann H. Insect calcium channels. Molecular cloning of an alpha 1-subunit from housefly (Musca domestica) muscle. Febs Letters. 339: 189-94. PMID 8313972 DOI: 10.1016/0014-5793(94)80413-3  1
1994 Moebius FF, Hanner M, Knaus HG, Weber F, Striessnig J, Glossmann H. Purification and amino-terminal sequencing of the high affinity phenylalkylamine Ca2+ antagonist binding protein from guinea pig liver endoplasmic reticulum. The Journal of Biological Chemistry. 269: 29314-20. PMID 7961902  1
1994 Mitterdorfer J, Froschmayr M, Grabner M, Striessnig J, Glossmann H. Calcium channels: the beta-subunit increases the affinity of dihydropyridine and Ca2+ binding sites of the alpha 1-subunit. Febs Letters. 352: 141-5. PMID 7925963 DOI: 10.1016/0014-5793(94)00938-4  1
1994 Berger W, Prinz H, Striessnig J, Kang HC, Haugland R, Glossmann H. Complex molecular mechanism for dihydropyridine binding to L-type Ca(2+)-channels as revealed by fluorescence resonance energy transfer. Biochemistry. 33: 11875-83. PMID 7918406  1
1993 Moebius FF, Burrows GG, Striessnig J, Glossmann H. Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action. Molecular Pharmacology. 43: 139-48. PMID 8429820  1
1993 Prinz H, Striessnig J. Ligand-induced accelerated dissociation of (+)-cis-diltiazem from L-type Ca2+ channels is simply explained by competition for individual attachment points. The Journal of Biological Chemistry. 268: 18580-5. PMID 8395510  1
1993 Hering S, Savchenko A, Strübing C, Lakitsch M, Striessnig J. Extracellular localization of the benzothiazepine binding domain of L-type Ca2+ channels. Molecular Pharmacology. 43: 820-6. PMID 8388993  1
1993 Lakitsch M, Knaus HG, Topar G, Romanin C, Boer R, Flockerzi D, Striessnig J, Schindler H, Hoeltje HD, Glossmann H. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67. Molecular Pharmacology. 43: 293-301. PMID 8381514  1
1993 Moebius FF, Burrows GG, Hanner M, Schmid E, Striessnig J, Glossmann H. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. Molecular Pharmacology. 44: 966-71. PMID 8246920  1
1993 Striessnig J, Berger W, Glossmann H. Molecular properties of voltage-dependent ca2+ channels in excitable tissues Cellular Physiology and Biochemistry. 3: 295-317. DOI: 10.1159/000154695  1
1992 Florio V, Striessnig J, Catterall WA. Purification and reconstitution of skeletal muscle calcium channels. Methods in Enzymology. 207: 529-46. PMID 1382201  1
1992 Catterall WA, Striessnig J. Receptor sites for Ca2+ channel antagonists. Trends in Pharmacological Sciences. 13: 256-62. PMID 1321525 DOI: 10.1016/0165-6147(92)90079-L  1
1992 Knaus HG, Striessnig J, Hering S, Marrer S, Schwenner E, Höltje HD, Glossmann H. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties. Molecular Pharmacology. 41: 298-307. PMID 1311409  1
1991 Glossmann H, Zech C, Striessnig J, Staudinger R, Hall L, Greenberg R, Armah BI. Very high affinity interaction of DPI 201-106 and BDF 8784 enantiomers with the phenylalkylamine-sensitive Ca2(+)-channel in Drosophila head membranes. British Journal of Pharmacology. 102: 446-52. PMID 1849770  1
1991 Grabner M, Friedrich K, Knaus HG, Striessnig J, Scheffauer F, Staudinger R, Koch WJ, Schwartz A, Glossmann H. Calcium channels from Cyprinus carpio skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 88: 727-31. PMID 1846962  1
1991 Striessnig J, Murphy BJ, Catterall WA. Dihydropyridine receptor of L-type Ca2+ channels: identification of binding domains for [3H](+)-PN200-110 and [3H]azidopine within the alpha 1 subunit. Proceedings of the National Academy of Sciences of the United States of America. 88: 10769-73. PMID 1660150  1
1991 Ahlijanian MK, Striessnig J, Catterall WA. Phosphorylation of an alpha 1-like subunit of an omega-conotoxin-sensitive brain calcium channel by cAMP-dependent protein kinase and protein kinase. The Journal of Biological Chemistry. 266: 20192-7. PMID 1657916  1
1991 Nakayama H, Taki M, Striessnig J, Glossmann H, Catterall WA, Kanaoka Y. Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine. Proceedings of the National Academy of Sciences of the United States of America. 88: 9203-7. PMID 1656465  1
1991 Haase H, Striessnig J, Holtzhauer M, Vetter R, Glossmann H. A rapid procedure for the purification of cardiac 1,4-dihydropyridine receptors from porcine heart. European Journal of Pharmacology. 207: 51-9. PMID 1655494 DOI: 10.1016/S0922-4106(05)80037-9  1
1990 Striessnig J, Glossmann H, Catterall WA. Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels. Proceedings of the National Academy of Sciences of the United States of America. 87: 9108-12. PMID 2174553  1
1990 Glossmann H, Striessnig J. Molecular properties of calcium channels. Reviews of Physiology, Biochemistry and Pharmacology. 114: 1-105. PMID 2155469  1
1990 Striessnig J, Scheffauer F, Mitterdorfer J, Schirmer M, Glossmann H. Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies. The Journal of Biological Chemistry. 265: 363-70. PMID 2152924  1
1989 Grassegger A, Striessnig J, Weiler M, Knaus HG, Glossmann H. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain. Naunyn-Schmiedeberg's Archives of Pharmacology. 340: 752-9. PMID 2561307 DOI: 10.1007/BF00169685  1
1989 Glossmann H, Striessnig J, Knaus HG, Müller J, Grassegger A, Höltje HD, Marrer S, Hymel L, Schindler HG. Structure of calcium channels. Annals of the New York Academy of Sciences. 560: 198-214. PMID 2545133 DOI: 10.1111/j.1749-6632.1989.tb24098.x  1
1989 Greenberg RM, Striessnig J, Koza A, Devay P, Glossmann H, Hall LM. Native and detergent-solubilized membrane extracts from Drosophila heads contain binding sites for phenylalkylamine calcium channel blockers Insect Biochemistry. 19: 309-322. DOI: 10.1016/0020-1790(89)90077-2  1
1989 Hymel L, Schindler H, Inui M, Fleischer S, Striessnig J, Glossmann H. A molecular model of excitation - contraction coupling at the skeletal muscle triad junction via coassociated oligomeric calcium channels Annals of the New York Academy of Sciences. 560: 185-188.  1
1988 Glossmann H, Striessnig J. Calcium channels. Vitamins and Hormones. 44: 155-328. PMID 2853487  1
1988 Striessnig J, Knaus HG, Glossmann H. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel. The Biochemical Journal. 253: 39-47. PMID 2844171  1
1988 Striessnig J, Meusburger E, Grabner M, Knaus HG, Glossmann H, Kaiser J, Schölkens B, Becker R, Linz W, Henning R. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166. Naunyn-Schmiedeberg's Archives of Pharmacology. 337: 331-40. PMID 2839780 DOI: 10.1007/BF00168847  1
1988 Hymel L, Striessnig J, Glossmann H, Schindler H. Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers. Proceedings of the National Academy of Sciences of the United States of America. 85: 4290-4. PMID 2454467  1
1988 Glossmann H, Striessnig J, Hymel L, Schindler H. Purification and reconstitution of calcium channel drug-receptor sites. Annals of the New York Academy of Sciences. 522: 150-61. PMID 2454049  1
1988 Striessnig J, Glossmann H. Characterization of the drug receptors of the purified skeletal muscle calcium channel. Progress in Clinical and Biological Research. 252: 35-40. PMID 2450374  1
1988 Glossmann H, Striessnig J. Structure and pharmacology of voltage-dependent calcium channels Isi Atlas of Science: Pharmacology. 2: 202-210.  1
1987 Knaus HG, Striessnig J, Koza A, Glossmann H. Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes. Naunyn-Schmiedeberg's Archives of Pharmacology. 336: 583-6. PMID 2830547 DOI: 10.1007/BF00169318  1
1987 Glossmann H, Striessnig J, Hymel L, Schindler H. Purified L-type calcium channels: only one single polypeptide (alpha 1-subunit) carries the drug receptor domains and is regulated by protein kinases. Biomedica Biochimica Acta. 46: S351-6. PMID 2449181  1
1987 Vaghy PL, Striessnig J, Miwa K, Knaus HG, Itagaki K, McKenna E, Glossmann H, Schwartz A. Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. The Journal of Biological Chemistry. 262: 14337-42. PMID 2443504  1
1987 Glossmann H, Striessnig J, Ferry DR, Goll A, Moosburger K, Schirmer M. Interaction between calcium channel ligands and calcium channels. Circulation Research. 61: I30-6. PMID 2443273  1
1987 Striessnig J, Knaus HG, Grabner M, Moosburger K, Seitz W, Lietz H, Glossmann H. Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. Febs Letters. 212: 247-53. PMID 2434359 DOI: 10.1016/0014-5793(87)81354-6  1
1987 Glossmann H, Ferry DR, Striessnig J, Goll A, Moosburger K. Resolving the structure of the Ca2+ channel by photoaffinity labelling Trends in Pharmacological Sciences. 8: 95-100. DOI: 10.1016/0165-6147(87)90082-4  1
1986 Striessnig J, Moosburger K, Goll A, Ferry DR, Glossmann H. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel. European Journal of Biochemistry / Febs. 161: 603-9. PMID 2431906 DOI: 10.1111/j.1432-1033.1986.tb10484.x  1
1986 Striessnig J, Goll A, Moosburger K, Glossmann H. Purified calcium channels have three allosterically coupled drug receptors. Febs Letters. 197: 204-10. PMID 2419161 DOI: 10.1016/0014-5793(86)80327-1  1
1985 Striessnig J, Zernig G, Glossmann H. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. European Journal of Biochemistry / Febs. 150: 67-77. PMID 2990927  1
1985 Striessnig J, Zernig G, Glossmann H. Ca2+ antagonist receptor sites on human red blood cell membranes. European Journal of Pharmacology. 108: 329-30. PMID 2985404 DOI: 10.1016/0014-2999(85)90460-1  1
1985 Glossmann H, Ferry DR, Goll A, Striessnig J, Zernig G. Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneimittel-Forschung. 35: 1917-35. PMID 2420337  1
1985 Glossmann H, Ferry DR, Goll A, Striessnig J, Schober M. Calcium channels: basic properties as revealed by radioligand binding studies. Journal of Cardiovascular Pharmacology. 7: S20-30. PMID 2414589  1
1984 Goll A, Ferry DR, Striessnig J, Schober M, Glossmann H. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. Febs Letters. 176: 371-7. PMID 6092142 DOI: 10.1016/0014-5793(84)81199-0  1
Show low-probability matches.